Bevacizumab to Treat Kaposi's Sarcoma in HIV-Positive and HIV-Negative Patients
Clinical trial NCT00055237 · COMPLETED
Trial details
- NCT number
- NCT00055237
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-02-26
- Primary completion
- 2010-03-15
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.